To further elucidate the molecular functions and underlying mechanisms of TPD52 in cancer, we immunoprecipitated exogenous TPD52 from T24 human bladder cancer cells and identified potential interacting proteins by mass spectrometry (MS) (Figure S1a, Supporting Information). This evidence concerns the gene TPD52 and urinary bladder carcinoma.